Sold by Mighty Ape
This volume presents a comprehensive overview on the drug discovery processes aimed at generating inhibitors for the treatment of malihnancies believed to be dependent on the gain of function of protein tyrosine kinases (RTKs). Specific topics include Src as a target for pharmaceutical intervention, JAK kinases in leukemias/lymphomas, platelet-derived growth factor, structural biology of PTKs, PI3-kinase inhibition, and phosphoproteomics in drug discovery and development.
We are committed to protecting your rights under the Consumer Guarantees Act and working with our suppliers to assist with warranty claims. Products sold by Mighty Ape will be covered by a Manufacturer's Warranty for at least a one-year period from the date of purchase.
Your warranty will cover any manufacturing defects which, if existing, will present themselves within this warranty period.
Your warranty will not cover normal wear and tear, faults caused by misuse, and accidents which cause damage or theft caused after delivery. Using the product in a way it is not designed for will void your warranty.
Please refer to our Help Centre for more information.